HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Zarzuelo Selected Research

Dyslipidemias (Dyslipidemia)

3/2009Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
9/2008Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
10/2005A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Zarzuelo Research Topics

Disease

43Colitis
10/2018 - 11/2002
29Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2018 - 11/2002
27Inflammation (Inflammations)
10/2018 - 11/2003
13Body Weight (Weight, Body)
10/2018 - 05/2005
11Hypertension (High Blood Pressure)
09/2013 - 09/2002
6Insulin Resistance
01/2017 - 02/2008
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2017 - 02/2008
6Necrosis
01/2015 - 05/2005
4Obesity
11/2013 - 10/2005
3Cardiomegaly (Heart Hypertrophy)
09/2013 - 09/2002
3Ulcerative Colitis
10/2011 - 06/2005
3Hyperinsulinism (Hyperinsulinemia)
04/2010 - 09/2008
3Dyslipidemias (Dyslipidemia)
03/2009 - 10/2005
3Proteinuria
08/2007 - 09/2002
2Hypersensitivity (Allergy)
01/2013 - 10/2011
2Food Hypersensitivity (Food Allergy)
07/2012 - 10/2011
2Hypertrophy
02/2010 - 04/2004
2Septic Shock (Toxic Shock Syndrome)
01/2009 - 09/2003
2Crohn Disease (Crohn's Disease)
11/2007 - 06/2005
2Cardiovascular Diseases (Cardiovascular Disease)
08/2007 - 02/2007
2Neoplasms (Cancer)
08/2006 - 02/2006
2Anorexia
03/2006 - 05/2005
1Dysbiosis
01/2017
1Endotoxemia
01/2017

Drug/Important Bio-Agent (IBA)

13Trinitrobenzenesulfonic AcidIBA
11/2016 - 11/2002
13AcidsIBA
04/2013 - 11/2003
11Peroxidase (Myeloperoxidase)IBA
10/2018 - 09/2002
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010 - 11/2002
9Dextrans (Dextran)FDA Link
11/2016 - 12/2004
9Alkaline PhosphataseIBA
06/2016 - 12/2004
9AntioxidantsIBA
04/2013 - 04/2004
8CytokinesIBA
06/2016 - 11/2003
8QuercetinIBA
12/2014 - 09/2002
6sodium sulfate (sodium bisulfate)FDA LinkGeneric
07/2015 - 12/2004
6Glutathione (Reduced Glutathione)IBA
05/2007 - 09/2002
5Dextran SulfateIBA
10/2018 - 02/2005
5FlavonoidsIBA
12/2014 - 09/2002
5Drinking WaterIBA
12/2011 - 12/2004
5HaptensIBA
10/2011 - 03/2004
5Ethanol (Ethyl Alcohol)IBA
01/2007 - 11/2003
4SodiumIBA
11/2016 - 02/2009
4Glucose (Dextrose)FDA LinkGeneric
01/2015 - 02/2008
4PrebioticsIBA
05/2014 - 03/2005
4Desoxycorticosterone Acetate (DOCA)FDA Link
09/2013 - 04/2004
4SaltsIBA
09/2013 - 04/2004
4Pharmaceutical PreparationsIBA
02/2013 - 03/2005
4Dietary FiberFDA Link
04/2010 - 11/2002
4Sulfasalazine (Azulfidine)FDA LinkGeneric
05/2009 - 05/2005
4Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2006 - 03/2005
4Antihypertensive Agents (Antihypertensives)IBA
02/2005 - 09/2002
3Interleukin-17 (Interleukin 17)IBA
10/2018 - 04/2013
3Therapeutic UsesIBA
11/2016 - 02/2013
3Anti-Bacterial Agents (Antibiotics)IBA
11/2016 - 12/2011
3Active Hexose Correlated CompoundIBA
12/2014 - 05/2007
3OligosaccharidesIBA
05/2014 - 03/2006
3caseinomacropeptideIBA
04/2014 - 05/2005
3Biomarkers (Surrogate Marker)IBA
11/2013 - 11/2003
3Desoxycorticosterone (Deoxycorticosterone)IBA
09/2013 - 04/2004
3Acetates (Acetic Acid Esters)FDA Link
09/2013 - 04/2004
3PolyphenolsIBA
04/2013 - 08/2007
3Sulfonic AcidsIBA
03/2013 - 02/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2010 - 11/2002
3NF-kappa B (NF-kB)IBA
08/2009 - 02/2005
32- hydroxy- 4- (2,2,3,3,3- pentafluoropropoxy)benzoic acidIBA
02/2009 - 11/2007
3GenisteinIBA
09/2007 - 09/2003
3Trefoil Factor-3IBA
05/2007 - 05/2005
2FructoseIBA
01/2017 - 05/2010
2Interleukin-6 (Interleukin 6)IBA
11/2016 - 09/2016
2Rutin (Rutoside)IBA
12/2014 - 02/2005
2Lactulose (Duphalac)FDA LinkGeneric
05/2014 - 03/2005
2Insulin (Novolin)FDA Link
11/2013 - 02/2010
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2013 - 10/2011
2ChemokinesIBA
04/2013 - 05/2007
2DinitrofluorobenzeneIBA
01/2013 - 10/2011
2Immunoglobulin G (IgG)IBA
01/2013 - 02/2009
2AntigensIBA
01/2013 - 07/2012
2Interleukin-4 (Interleukin 4)IBA
01/2013 - 05/2005
2Minocycline (Cyclops)FDA LinkGeneric
12/2011 - 04/2011
2Protein Isoforms (Isoforms)IBA
02/2011 - 12/2004
2Butyrates (Butyrate)IBA
11/2010 - 08/2006
2AdiponectinIBA
04/2010 - 10/2005
2Acetylcholine (Acetylcholine Chloride)FDA Link
02/2010 - 09/2003
2Biological ProductsIBA
03/2009 - 10/2008
2SalicylatesIBA
02/2009 - 07/2008
2LipopolysaccharidesIBA
01/2009 - 09/2003
2Leukotriene B4IBA
04/2005 - 03/2005
2NitritesIBA
02/2005 - 09/2002
2quercitrinIBA
02/2005 - 12/2004
2NitratesIBA
02/2005 - 09/2002
2Verapamil (Calan)FDA LinkGeneric
04/2004 - 04/2004
2MineralocorticoidsIBA
04/2004 - 04/2004
1Toll-Like Receptor 4IBA
10/2018
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
10/2018
1Diphosphonates (Bisphosphonates)IBA
11/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2016
1NitrogenIBA
11/2016
1Alendronate (Alendronate Sodium)FDA LinkGeneric
11/2016
1Ibandronic Acid (Boniva)FDA Link
11/2016
1Pamidronate (Aredia)FDA LinkGeneric
11/2016

Therapy/Procedure

2Therapeutics
02/2010 - 07/2008